Farmas USA

Xq ultimamente no deja de haber news los lunes.

NVAX

edito: y fijate en semanal que rica velica

Siiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii, jajaja

nvax

Rica rica, y el IBB en la semana -0.68% NVAX +6.67%, eso también queda bonito :)

NVAX

Confirmado el veredicto del juez AMRN vs AZN

http://investor.amarincorp.com/secfiling.cfm?filingid=1193125-14-413357&CIK=897448

On November 14, 2014, based on a representation from AstraZeneca Pharmaceuticals LP that the commercial launch of Epanova™ in the United States is not imminent, the United States District Court for the District of Delaware dismissed, without prejudice ( i.e. , preserving the ability for Amarin to later re-file the suit), Amarin’s complaint against Omthera Pharmaceuticals, Inc., and its parent company, AstraZeneca Pharmaceuticals LP. The complaint sought injunctive relief and monetary damages for infringement of Amarin’s U.S. Patent No. 8,663,662 (the “Patent”). In the complaint, Amarin alleged infringement of the Patent arising from the anticipated launch of Epanova TM  in the United States following the product’s FDA approval in May 2014. The court found that for the case to proceed, the launch of Epanova must be imminent. The court was persuaded by the defendants’ representation that Epanova™ would not be launched in 2014 and by the defendants’ representation that it would provide notice to Amarin prior to any product launch. The court indicated that it relied on those representations in rendering its decision and noted that they are binding on the defendants as a matter of judicial estoppel. Amarin intends to pursue this litigation vigorously if and when any such notice is received and plans to aggressively protect its intellectual property rights.

-----------------------------------

Ahora lo que se pregunta el pueblo es : vamosa ver, Epanova tenia previsto ser lanzada al mercado en Q4 2014 ... como que el lanzamiento no es inminente? Porque se retrasa? Algun problema con proveedores? O negociaciones bajo mesa?

AMRN

Vamos a tener teorias varias estos dias my friend!.

Google finance indica 23% de institucionales ... y ese ha sido mi valor de referencia estos dias.
Nasdaq.com indica hoy 49% ... de ser cierto es tremendo!

SNTA

Snta

Finviz da también un 23% pero lo que es un escándalo es la pinta que tiene el semanal de cara a la conferencia de la semana que viene. Que buena pinta!

Entrada actualizada
http://nasdaqlandia.com/arna-arena-pharmaceuticals-inc-recuerden-que-no-solo-es-belviq-actu-15112014.html#comment-163996

ARNA